Richard U. De Schutter Appointed to Varian, Inc. Board of Directors
De Schutter has a distinguished background and reputation in the pharmaceutical industry and served as chief executive officer of G.D. Searle & Company prior to joining Dupont Pharmaceuticals in 2000.
"We are very pleased to have Richard De Schutter as a member of the Varian, Inc. board," said Allen J. Lauer, president and CEO, Varian, Inc. "The company's primary strategy continues to be expanding our drive into life science applications of our products, particularly into pharmaceutical labs. Richard's exceptional background in the pharmaceutical industry and his diverse experience in managing international companies are invaluable assets to Varian, Inc. as we continue to execute our business goals."
De Schutter's other current board memberships include ING Americas; General Binding Corporation; Smith & Nephew plc, and Medpointe. He also serves on the Advisory Board of University of Arizona.
De Schutter received his bachelor's of science and M.A. in chemical engineering from the University of Arizona.
Most read news
Organizations
Other news from the department people
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.